OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
Tonia Kirschner, Matthias Müller, Daniel Rauh
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6044-6051
Closed Access | Times Cited: 9
Tonia Kirschner, Matthias Müller, Daniel Rauh
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6044-6051
Closed Access | Times Cited: 9
Showing 9 citing articles:
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Targeting KRASG13C: Exploring Warhead Orientation with Cyclic Linker-Based Inhibitors
Tonia Kirschner, J. M. Rodríguez, Emerson G. Moreira, et al.
Research Square (Research Square) (2025)
Closed Access
Tonia Kirschner, J. M. Rodríguez, Emerson G. Moreira, et al.
Research Square (Research Square) (2025)
Closed Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
Mirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117830-117830
Closed Access | Times Cited: 3
Mirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117830-117830
Closed Access | Times Cited: 3
Innovative Therapeutic Approaches Targeting K-Ras: Analysis of Macrocyclic Compounds, Peptidomimetics, and Pyridopyrimidine Inhibitors
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1196-1198
Open Access | Times Cited: 1
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1196-1198
Open Access | Times Cited: 1
Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer
Gareth Pollin, Gwen Lomberk, Angela Mathison, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 1996-2001
Open Access
Gareth Pollin, Gwen Lomberk, Angela Mathison, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 1996-2001
Open Access
Advancements in Targeted Therapeutics: Integrating Metabolic Modulation, Immune Engineering, and Biologic Formulation Technologies
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1430-1432
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1430-1432
Open Access
Advances in Cancer Treatment and Monitoring: Insights from KRAS Inhibitors and Germline Epitope Burden Monitoring
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1815-1817
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1815-1817
Open Access
Suite of Biochemical and Cell-Based Assays for the Characterization of Kirsten Rat Sarcoma (KRAS) Inhibitors and Degraders
Medhanie Kidane, Rene M. Hoffman, Jennifer K. Wolfe-Demarco, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3921-3934
Open Access
Medhanie Kidane, Rene M. Hoffman, Jennifer K. Wolfe-Demarco, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3921-3934
Open Access
